Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumors.
Santamaria S, Delgado M, Botas M, Castellano E, Corraliza-Gorjon I, Lafuente P, Muñoz-Calleja C, Toribio ML, Kremer L, Garcia-Sanz JA.
Santamaria S, et al. Among authors: garcia sanz ja.
Front Immunol. 2022 Jul 27;13:825635. doi: 10.3389/fimmu.2022.825635. eCollection 2022.
Front Immunol. 2022.
PMID: 35967322
Free PMC article.